Payal Shah

17PUBLICATIONS
200CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsApplications in healthMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 20, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

|Jan 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2.

Nadine M Tung, Mark E Robson, Tianyu Li

|Jun 24, 2024
Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1, BRCA2, and Lynch Syndrome.

Charles M Bowen, Kaitlin Demarest, Eduardo Vilar

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Jan 04, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Isabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz

|Oct 04, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson

Pageof 3

Frequent Collaborators

5 joint publications

Susan M Domchek

4 joint publications

Cesar Santa-Maria

3 joint publications

Nadine Tung

3 joint publications

Eric P Winer